Early Fluid Resolution Predicts Faricimab Durability

Post hoc analysis suggests rapid retinal fluid resolution may help identify patients with nAMD who can maintain longer faricimab dosing intervals.

By
Conexiant News Staff
March 11, 2026
4 min

Conexiant

Original Source(s)

Conexiant

Early Fluid Resolution Predicts Faricimab Durability

by Conexiant News Staff
March 11, 2026

Related Content

Bmc Ophthalmology

Vascular Alterations in the Choroid of Eyes Affected by Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy: Fresh Perspectives

by Nicola Valsecchi, Matteo Elifani, Chiara Veronese, Emilia Maggio, Antonio Moramarco, Mohammed Abdul Rasheed, Grazia Pertile, Kiran Kumar Vupparaboina, Jay Chhablani, Luigi Fontana, Maurizio Mete
February 11, 2026

Jama Ophthalmology

Nonexudative Macular Neovascularization in Age-Related Macular Degeneration

by Sridevi Thottarath, Sarega Gurudas, Syed Kubravi, Dimitrios Kazantzis, Ayse Merve Keskin, Sobha Sivaprasad, EYENEON Study Group, Benjamin Burton, Geeta Menon, Manju Chandran, Ian Pearce, Savita Madhusudhan, Anna Grabowska, Faruque Ghanchi, James Talks, Richard Gale, Martin McKibbin, Ajay Kotagiri, Niro Narendran, Afsar Jafree, Saad Younis, Claire Bailey, Priya Prakash, Christiana Dinah, Louise Downey, Andrew Lottery, Paritosh Shah, Romi Chhabra, Narendra Dhingra, Indra Dias, Mary Freeman, Daren Hanumunthadu
May 1, 2026

Retinal Physician

New Product Applications: Introducing the Cirrus 6000

Discover how Zeiss's Cirrus 6000 OCT device revolutionizes eye care with faster analysis and enhanced capabilities for disease diagnosis and treatment.

by Karen Appold, contributing writer
March 1, 2025
5 min